Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,825 | 139 | 96.5% |
| Education | $101.35 | 3 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $487.92 | 31 | $0 (2024) |
| PFIZER INC. | $353.61 | 17 | $0 (2023) |
| Daiichi Sankyo Inc. | $241.99 | 9 | $0 (2022) |
| Caldera Medical, Inc | $128.15 | 1 | $0 (2023) |
| Baxter Healthcare | $125.21 | 2 | $0 (2024) |
| Avion Pharmaceuticals | $123.17 | 8 | $0 (2022) |
| TherapeuticsMD, Inc. | $121.75 | 8 | $0 (2022) |
| Astellas Pharma US Inc | $120.65 | 4 | $0 (2024) |
| Minerva Surgical, Inc | $117.35 | 5 | $0 (2022) |
| SCYNEXIS, Inc. | $92.44 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $462.09 | 18 | Baxter Healthcare ($125.21) |
| 2023 | $436.19 | 17 | Caldera Medical, Inc ($128.15) |
| 2022 | $694.61 | 36 | ABBVIE INC. ($194.51) |
| 2021 | $354.75 | 20 | PFIZER INC. ($76.75) |
| 2020 | $119.15 | 7 | AbbVie Inc. ($53.94) |
| 2019 | $322.33 | 15 | Daiichi Sankyo Inc. ($148.86) |
| 2018 | $189.13 | 10 | PFIZER INC. ($41.34) |
| 2017 | $348.22 | 19 | PFIZER INC. ($79.35) |
All Payment Transactions
142 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $16.08 | General |
| Category: Endocrinology | ||||||
| 10/24/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 09/12/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Biological | ||||||
| 08/05/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $15.47 | General |
| Category: Endocrinology | ||||||
| 07/25/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $84.62 | General |
| Category: Surgical Care | ||||||
| 06/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Obesity | ||||||
| 06/27/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $40.59 | General |
| Category: Surgical Care | ||||||
| 06/17/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: WOMENS HEALTH | ||||||
| 05/15/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Hyperthyroidism | ||||||
| 05/13/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: Endocrinology | ||||||
| 05/03/2024 | Mission Pharmacal Company | CITRANATAL MEDLEY (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: PRENATAL VITAMIN & MINERAL | ||||||
| 04/22/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: ETONOGESTREL | ||||||
| 03/18/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Neurology | ||||||
| 03/11/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: CONTRACEPTIVE | ||||||
| 01/10/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Neurology | ||||||
| 01/07/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: Endocrinology | ||||||
| 12/21/2023 | MISSION PHARMACAL COMPANY | CITRANATAL (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: PRENATAL VITAMIN & MINERAL | ||||||
| 12/21/2023 | Mission Pharmacal Company | CITRANATAL (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: PRENATAL VITAMIN & MINERAL | ||||||
| 12/05/2023 | Medtronic, Inc. | V-LOC 180 (Device) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Wound Closure | ||||||
| 11/21/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: WOMENS HEALTH | ||||||
| 11/14/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: non-opioid analgesic | ||||||
| 11/13/2023 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: WOMENS HEALTH | ||||||
| 11/06/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 280 | 338 | $27,901 | $13,850 |
| 2022 | 6 | 269 | 320 | $35,031 | $16,950 |
| 2021 | 5 | 279 | 361 | $38,890 | $20,169 |
| 2020 | 6 | 307 | 383 | $42,196 | $18,860 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 95 | $11,400 | $5,374 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 32 | $5,696 | $2,603 | 45.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 56 | 56 | $3,528 | $2,084 | 59.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 34 | 34 | $2,482 | $1,400 | 56.4% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 76 | 76 | $1,900 | $1,344 | 70.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 12 | 12 | $2,400 | $901.36 | 37.6% |
| 87210 | Smear for infectious agents | Office | 2023 | 13 | 13 | $195.00 | $74.10 | 38.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 20 | $300.00 | $68.20 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 104 | $12,480 | $6,245 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 70 | $12,460 | $5,481 | 44.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 49 | 49 | $3,577 | $2,033 | 56.8% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 72 | 72 | $1,800 | $1,283 | 71.3% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 12 | 12 | $2,400 | $1,010 | 42.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,314 | $898.65 | 38.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 136 | $16,320 | $8,385 | 51.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 78 | $13,884 | $6,822 | 49.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 57 | 57 | $4,161 | $2,397 | 57.6% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 77 | 77 | $1,925 | $1,390 | 72.2% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 13 | 13 | $2,600 | $1,175 | 45.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 130 | $15,600 | $6,626 | 42.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 82 | 83 | $14,774 | $5,799 | 39.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 68 | 68 | $4,964 | $2,823 | 56.9% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 14 | 15 | $3,000 | $1,427 | 47.6% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 76 | 76 | $1,900 | $1,348 | 70.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $1,958 | $837.24 | 42.8% |
About Dr. Jon Ricks, M.D
Dr. Jon Ricks, M.D is a Specialist healthcare provider based in Frisco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316938632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Ricks, M.D has received a total of $2,926 in payments from pharmaceutical and medical device companies, with $462.09 received in 2024. These payments were reported across 142 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($2,825).
As a Medicare-enrolled provider, Ricks has provided services to 1,135 Medicare beneficiaries, totaling 1,402 services with total Medicare billing of $69,828. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Frisco, TX
- Active Since 11/04/2005
- Last Updated 02/27/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1316938632
Products in Payments
- INJECTAFER (Drug) $241.99
- PREMARIN (Drug) $194.23
- LILETTA (Drug) $172.57
- Desara (Device) $128.15
- TISSEEL (Biological) $125.21
- LO LOESTRIN FE (Drug) $102.36
- ANNOVERA (Drug) $91.52
- Balcoltra (Drug) $86.95
- NEOX (Medical Supply) $84.66
- PREMARIN ORALS (Drug) $79.35
- ORIAHNN (Drug) $78.33
- Orilissa (Drug) $72.98
- MYFEMBREE (Drug) $66.59
- Tirosint (Drug) $59.74
- NEXPLANON (Drug) $50.82
- Veozah (Drug) $45.66
- BIOFIX (Device) $43.30
- Caiman Vessel Sealers (Device) $41.41
- ORILISSA (Drug) $38.21
- Tymlos (Biological) $35.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Frisco
John Meiser, Md, MD
Specialist — Payments: $34,041
Mickey Morgan, M.d, M.D
Specialist — Payments: $31,073
Brian Welch, Md, MD
Specialist — Payments: $17,756
Dr. Jose Mandujano, M.d, M.D
Specialist — Payments: $12,003
Swati Ellendula, M.d, M.D
Specialist — Payments: $6,336
Dr. Vishnu Kalidindi, M.d, M.D
Specialist — Payments: $5,166